A promising new therapy to stop Parkinson's disease in its tracks has been developed by scientists who found that a small molecule, MCC950, stopped the development of Parkinson's in several animal models. The team hope to commence human clinical trials in 2020.
A promising new therapy to stop Parkinson's disease in its tracks has been developed by scientists who found that a small molecule, MCC950, stopped the development of Parkinson's in several animal models. The team hope to commence human clinical trials in 2020.
Share this Article
Recommended